| Dr Gustavo E Guajardo Salinas, MD | |
|
18707 Hardy Oak Blvd Ste 320, San Antonio, TX 78258-4890 | |
| (210) 614-0880 | |
| (210) 692-0258 |
| Full Name | Dr Gustavo E Guajardo Salinas |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 19 Years |
| Location | 18707 Hardy Oak Blvd Ste 320, San Antonio, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144403387 | NPI | - | NPPES |
| 375784102 | Medicaid | TX | |
| E-8210 | Other | AR | MED. LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | P0392 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Medical Center | San antonio, TX | Hospital |
| Methodist Hospital | San antonio, TX | Hospital |
| Methodist Hospital Stone Oak | San antonio, TX | Hospital |
| Christus Santa Rosa Medical Center | San antonio, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Oncology Pa | 5395658934 | 855 |
News Archive
A team of academics from the University of Leicester has been instrumental in shaping National Institute for Health and Care Excellence (NICE) guidance that will influence medical policy towards diabetes prevention nationwide.
Due to sample size limitations, previous studies of DMARD use and COVID-19 outcomes have combined several different rheumatic diseases and medications, and investigated a single outcome- for example, the risk of hospitalization.
ThromboGenics NV, a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announced today that it has been shortlisted for both the "Biotech Company of the Year" and "Licensing Deal of the Year" awards at the Scrip Awards 2009.
Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that it has signed a licensing agreement with the international pharmaceutical company Boehringer Ingelheim. The deal will aim to further extend marketing of Marinomed's anti-viral nasal spray for the treatment of the Common Cold to all of Europe (except Austria and UK), Russia and CIS, South America, parts of Asia and Australia.
Research carried out by the University of Kent with doctors on the neonatal unit at the William Harvey Hospital and Brunel University have provided further insight into the biology of premature birth, with findings that may have implications for treating premature babies.
› Verified 9 days ago
| Entity Name | Texas Oncology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944101 PECOS PAC ID: 5395658934 Enrollment ID: O20031124000323 |
News Archive
A team of academics from the University of Leicester has been instrumental in shaping National Institute for Health and Care Excellence (NICE) guidance that will influence medical policy towards diabetes prevention nationwide.
Due to sample size limitations, previous studies of DMARD use and COVID-19 outcomes have combined several different rheumatic diseases and medications, and investigated a single outcome- for example, the risk of hospitalization.
ThromboGenics NV, a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announced today that it has been shortlisted for both the "Biotech Company of the Year" and "Licensing Deal of the Year" awards at the Scrip Awards 2009.
Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that it has signed a licensing agreement with the international pharmaceutical company Boehringer Ingelheim. The deal will aim to further extend marketing of Marinomed's anti-viral nasal spray for the treatment of the Common Cold to all of Europe (except Austria and UK), Russia and CIS, South America, parts of Asia and Australia.
Research carried out by the University of Kent with doctors on the neonatal unit at the William Harvey Hospital and Brunel University have provided further insight into the biology of premature birth, with findings that may have implications for treating premature babies.
› Verified 9 days ago
| Entity Name | Bhs Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598958431 PECOS PAC ID: 7315019593 Enrollment ID: O20080703000069 |
News Archive
A team of academics from the University of Leicester has been instrumental in shaping National Institute for Health and Care Excellence (NICE) guidance that will influence medical policy towards diabetes prevention nationwide.
Due to sample size limitations, previous studies of DMARD use and COVID-19 outcomes have combined several different rheumatic diseases and medications, and investigated a single outcome- for example, the risk of hospitalization.
ThromboGenics NV, a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announced today that it has been shortlisted for both the "Biotech Company of the Year" and "Licensing Deal of the Year" awards at the Scrip Awards 2009.
Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that it has signed a licensing agreement with the international pharmaceutical company Boehringer Ingelheim. The deal will aim to further extend marketing of Marinomed's anti-viral nasal spray for the treatment of the Common Cold to all of Europe (except Austria and UK), Russia and CIS, South America, parts of Asia and Australia.
Research carried out by the University of Kent with doctors on the neonatal unit at the William Harvey Hospital and Brunel University have provided further insight into the biology of premature birth, with findings that may have implications for treating premature babies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gustavo E Guajardo Salinas, MD Po Box 911230, Dallas, TX 75391-1230 Ph: (972) 997-8000 | Dr Gustavo E Guajardo Salinas, MD 18707 Hardy Oak Blvd Ste 320, San Antonio, TX 78258-4890 Ph: (210) 614-0880 |
News Archive
A team of academics from the University of Leicester has been instrumental in shaping National Institute for Health and Care Excellence (NICE) guidance that will influence medical policy towards diabetes prevention nationwide.
Due to sample size limitations, previous studies of DMARD use and COVID-19 outcomes have combined several different rheumatic diseases and medications, and investigated a single outcome- for example, the risk of hospitalization.
ThromboGenics NV, a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announced today that it has been shortlisted for both the "Biotech Company of the Year" and "Licensing Deal of the Year" awards at the Scrip Awards 2009.
Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that it has signed a licensing agreement with the international pharmaceutical company Boehringer Ingelheim. The deal will aim to further extend marketing of Marinomed's anti-viral nasal spray for the treatment of the Common Cold to all of Europe (except Austria and UK), Russia and CIS, South America, parts of Asia and Australia.
Research carried out by the University of Kent with doctors on the neonatal unit at the William Harvey Hospital and Brunel University have provided further insight into the biology of premature birth, with findings that may have implications for treating premature babies.
› Verified 9 days ago
James Richard Garrison Jr., M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 4330 Medical Dr, Suite 325, San Antonio, TX 78229 Phone: 210-615-7700 Fax: 210-615-1782 | |
John C Russell, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 2731 Oak Bluff, San Antonio, TX 78230 Phone: 210-492-9131 Fax: 210-492-9131 | |
Dr. Dawn Szu-fei Hui, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 8300 Floyd Curl Dr Fl 3, San Antonio, TX 78229 Phone: 210-450-0999 Fax: 210-450-4965 | |
Dr. Francisco Bernardo Rodriguez Iv, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 19234 Stonehue, San Antonio, TX 78258 Phone: 210-837-3125 | |
Enoch Ching, CCP Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 3463 Magic Dr, San Antonio, TX 78229 Phone: 210-614-8101 | |
Thomas Ross Pollard, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 8715 Village Dr Ste 608, San Antonio, TX 78217 Phone: 210-298-4311 |